Cargando…
Multisite Dopamine Sensing With Femtomolar Resolution Using a CMOS Enabled Aptasensor Chip
Many biomarkers including neurotransmitters are found in external body fluids, such as sweat or saliva, but at lower titration levels than they are present in blood. Efficient detection of such biomarkers thus requires, on the one hand, to use techniques offering high sensitivity, and, on the other...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204155/ https://www.ncbi.nlm.nih.gov/pubmed/35720700 http://dx.doi.org/10.3389/fnins.2022.875656 |
_version_ | 1784728853959147520 |
---|---|
author | Sessi, Violetta Ibarlucea, Bergoi Seichepine, Florent Klinghammer, Stephanie Ibrahim, Imad Heinzig, André Szabo, Nadine Mikolajick, Thomas Hierlemann, Andreas Frey, Urs Weber, Walter M. Baraban, Larysa Cuniberti, Gianaurelio |
author_facet | Sessi, Violetta Ibarlucea, Bergoi Seichepine, Florent Klinghammer, Stephanie Ibrahim, Imad Heinzig, André Szabo, Nadine Mikolajick, Thomas Hierlemann, Andreas Frey, Urs Weber, Walter M. Baraban, Larysa Cuniberti, Gianaurelio |
author_sort | Sessi, Violetta |
collection | PubMed |
description | Many biomarkers including neurotransmitters are found in external body fluids, such as sweat or saliva, but at lower titration levels than they are present in blood. Efficient detection of such biomarkers thus requires, on the one hand, to use techniques offering high sensitivity, and, on the other hand, to use a miniaturized format to carry out diagnostics in a minimally invasive way. Here, we present the hybrid integration of bottom-up silicon-nanowire Schottky-junction FETs (SiNW SJ-FETs) with complementary-metal–oxide–semiconductor (CMOS) readout and amplification electronics to establish a robust biosensing platform with 32 × 32 aptasensor measurement sites at a 100 μm pitch. The applied hetero-junctions yield a selective biomolecular detection down to femtomolar concentrations. Selective and multi-site detection of dopamine is demonstrated at an outstanding sensitivity of ∼1 V/fM. The integrated platform offers great potential for detecting biomarkers at high dilution levels and could be applied, for example, to diagnosing neurodegenerative diseases or monitoring therapy progress based on patient samples, such as tear liquid, saliva, or eccrine sweat. |
format | Online Article Text |
id | pubmed-9204155 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92041552022-06-18 Multisite Dopamine Sensing With Femtomolar Resolution Using a CMOS Enabled Aptasensor Chip Sessi, Violetta Ibarlucea, Bergoi Seichepine, Florent Klinghammer, Stephanie Ibrahim, Imad Heinzig, André Szabo, Nadine Mikolajick, Thomas Hierlemann, Andreas Frey, Urs Weber, Walter M. Baraban, Larysa Cuniberti, Gianaurelio Front Neurosci Neuroscience Many biomarkers including neurotransmitters are found in external body fluids, such as sweat or saliva, but at lower titration levels than they are present in blood. Efficient detection of such biomarkers thus requires, on the one hand, to use techniques offering high sensitivity, and, on the other hand, to use a miniaturized format to carry out diagnostics in a minimally invasive way. Here, we present the hybrid integration of bottom-up silicon-nanowire Schottky-junction FETs (SiNW SJ-FETs) with complementary-metal–oxide–semiconductor (CMOS) readout and amplification electronics to establish a robust biosensing platform with 32 × 32 aptasensor measurement sites at a 100 μm pitch. The applied hetero-junctions yield a selective biomolecular detection down to femtomolar concentrations. Selective and multi-site detection of dopamine is demonstrated at an outstanding sensitivity of ∼1 V/fM. The integrated platform offers great potential for detecting biomarkers at high dilution levels and could be applied, for example, to diagnosing neurodegenerative diseases or monitoring therapy progress based on patient samples, such as tear liquid, saliva, or eccrine sweat. Frontiers Media S.A. 2022-06-03 /pmc/articles/PMC9204155/ /pubmed/35720700 http://dx.doi.org/10.3389/fnins.2022.875656 Text en Copyright © 2022 Sessi, Ibarlucea, Seichepine, Klinghammer, Ibrahim, Heinzig, Szabo, Mikolajick, Hierlemann, Frey, Weber, Baraban and Cuniberti. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Sessi, Violetta Ibarlucea, Bergoi Seichepine, Florent Klinghammer, Stephanie Ibrahim, Imad Heinzig, André Szabo, Nadine Mikolajick, Thomas Hierlemann, Andreas Frey, Urs Weber, Walter M. Baraban, Larysa Cuniberti, Gianaurelio Multisite Dopamine Sensing With Femtomolar Resolution Using a CMOS Enabled Aptasensor Chip |
title | Multisite Dopamine Sensing With Femtomolar Resolution Using a CMOS Enabled Aptasensor Chip |
title_full | Multisite Dopamine Sensing With Femtomolar Resolution Using a CMOS Enabled Aptasensor Chip |
title_fullStr | Multisite Dopamine Sensing With Femtomolar Resolution Using a CMOS Enabled Aptasensor Chip |
title_full_unstemmed | Multisite Dopamine Sensing With Femtomolar Resolution Using a CMOS Enabled Aptasensor Chip |
title_short | Multisite Dopamine Sensing With Femtomolar Resolution Using a CMOS Enabled Aptasensor Chip |
title_sort | multisite dopamine sensing with femtomolar resolution using a cmos enabled aptasensor chip |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204155/ https://www.ncbi.nlm.nih.gov/pubmed/35720700 http://dx.doi.org/10.3389/fnins.2022.875656 |
work_keys_str_mv | AT sessivioletta multisitedopaminesensingwithfemtomolarresolutionusingacmosenabledaptasensorchip AT ibarluceabergoi multisitedopaminesensingwithfemtomolarresolutionusingacmosenabledaptasensorchip AT seichepineflorent multisitedopaminesensingwithfemtomolarresolutionusingacmosenabledaptasensorchip AT klinghammerstephanie multisitedopaminesensingwithfemtomolarresolutionusingacmosenabledaptasensorchip AT ibrahimimad multisitedopaminesensingwithfemtomolarresolutionusingacmosenabledaptasensorchip AT heinzigandre multisitedopaminesensingwithfemtomolarresolutionusingacmosenabledaptasensorchip AT szabonadine multisitedopaminesensingwithfemtomolarresolutionusingacmosenabledaptasensorchip AT mikolajickthomas multisitedopaminesensingwithfemtomolarresolutionusingacmosenabledaptasensorchip AT hierlemannandreas multisitedopaminesensingwithfemtomolarresolutionusingacmosenabledaptasensorchip AT freyurs multisitedopaminesensingwithfemtomolarresolutionusingacmosenabledaptasensorchip AT weberwalterm multisitedopaminesensingwithfemtomolarresolutionusingacmosenabledaptasensorchip AT barabanlarysa multisitedopaminesensingwithfemtomolarresolutionusingacmosenabledaptasensorchip AT cunibertigianaurelio multisitedopaminesensingwithfemtomolarresolutionusingacmosenabledaptasensorchip |